Furthermore, NEDD4 knockdown improved cisplatin sensitivity in nasopharyngeal cancer cells that were resistant to the drug, showing that NEDD4 affects the level of sensitivity of cancer cells to it. This evidence concerns the gene NEDD4 and nasopharyngeal carcinoma.